These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28031413)

  • 1. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.
    Wielgos ME; Rajbhandari R; Cooper TS; Wei S; Nozell S; Yang ES
    Mol Cancer Res; 2017 Mar; 15(3):340-347. PubMed ID: 28031413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
    Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
    BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
    Stanley J; Klepczyk L; Keene K; Wei S; Li Y; Forero A; Grizzle W; Wielgos M; Brazelton J; LoBuglio AF; Yang ES
    Breast Cancer Res Treat; 2015 Apr; 150(3):569-79. PubMed ID: 25833211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
    Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
    Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1.
    Mi Y; Liu F; Liang X; Liu S; Huang X; Sang M; Geng C
    Neoplasma; 2019 Jan; 66(1):54-62. PubMed ID: 30509089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
    Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
    Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.
    Xiao M; Guo J; Xie L; Yang C; Gong L; Wang Z; Cai J
    Mol Cancer Res; 2020 Mar; 18(3):436-447. PubMed ID: 31722968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
    Liu K; Zhang C; Li T; Ding Y; Tu T; Zhou F; Qi W; Chen H; Sun X
    Int J Oncol; 2015; 46(6):2526-34. PubMed ID: 25846193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
    Wang M; Hu Y; Amatangelo MD; Stearns ME
    Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.
    Luo J; Jin J; Yang F; Sun Z; Zhang W; Shi Y; Xu J; Guan X
    Int J Biol Sci; 2016; 12(12):1500-1510. PubMed ID: 27994514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
    Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.
    Shi Y; Cao T; Huang H; Lian C; Yang Y; Wang Z; Ma J; Xia J
    Cell Cycle; 2017; 16(24):2396-2403. PubMed ID: 28980872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
    Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
    Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M; Zhao X; Yuan X; Jiang J; Li P
    Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.